• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    4.60 Down 0.47(9.27%) Feb 8, 4:00PM EST
    Prev Close:5.07
    Open:5.01
    Bid:4.30 x 2000
    Ask:4.98 x 100
    1y Target Est:7.88
    Beta:1.64489
    Next Earnings Date:23-Feb-16ARIA Earnings announcement
    Day's Range:4.57 - 5.02
    52wk Range:4.57 - 10.07
    Volume:4,058,438
    Avg Vol (3m):3,448,030
    Market Cap:870.75M
    P/E (ttm):N/A
    EPS (ttm):-0.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 9.27%870.75M
    PFEDown 1.62%176.32B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.24
    Quarterly EPS Est (Dec-15) :-0.31
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback